SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Laboratories informs about loss of share certificates

23 Apr 2024 Evaluate
Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015 and based on the intimation received from the Company's Registrar and Share Transfer Agent (‘RTA’) Purva Sharegistry (India) on April 22, 2024, Chemo Pharma Laboratories has informed that the Company has received a letter from the shareholder regarding loss of share certificate(s) with a request for issue of duplicate share certificate(s) in lieu thereof. The duplicate share certificate will be issued after the receipt of all necessary documents from shareholders. Details of the shareholders and share certificate are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Starsource Multitrad Share Price

116.50 -6.10 (-4.98%)
17-Apr-2026 13:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.50
Dr. Reddys Lab 1230.00
Cipla 1236.55
Zydus Lifesciences 945.85
Lupin 2307.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×